Table 3.
Level of treatment resistance of illness |
Number of previous adequate pharmacologic trials |
Presence of acute suicidality |
Presence of psychiatric or other medical comorbidity |
Previous response to ketamine |
Access to ketamine infusions |
Risk of ketamine abuse/dependence |
Risk of diversion |